期刊文献+

下调叉头转录因子M1基因表达对非小细胞肺癌细胞生长与侵袭能力的影响 被引量:10

Role of inhibition of transcription factor fockhead box M1 expression by RNA interference in the proliferation and invasiveness of non-small cell lung cancer cells
原文传递
导出
摘要 目的研究用叉头转录因子M1(FoxM1)基因小干扰RNA下调非小细胞肺癌(NSCLC)细胞株FoxM1基因表达后细胞增殖与侵袭能力的改变,为开发新的NSCLC靶向治疗方法提供依据。方法设计靶向FoxM1小干扰RNA(siFoxM1),分别以siFoxM1和无关对照siRNA转染人NSCLC细胞株SPC—A-1、A549和LTEP-a-2,采用实时逆转录PCR和蛋白质印迹法检测FoxM1 mRNA和蛋白表达,采用集落形成试验、划痕试验和细胞侵袭试验研究下调FoxM1基因表达对细胞增殖、迁移和侵袭能力的影响。结果转染siFoxM1可高效特异地下调SPC—A-1、A549和LTEP-a-2细胞的FoxM1 mRNA表达(分别下降83.9%、83.6%、88.6%)和蛋白表达。转染siFoxM1的SPC—A-1、A549和LTEP-a-2细胞集落形成数[分别为(136.0±15.5)、(87.0±2.6)和(121.7±9.4)个]和穿膜细胞数[分别为(19.2±2.5)、(4.2±0.8)和(6.2±1.8)个]均明显低于转染无关对照siRNA细胞[集落形成数分别为(222.3±20.5)、(164.7±14.1)和(260.7±13.5)个,穿膜细胞数分别为(81.4±6.2)、(39.2±4.6)和(35.6±3.0)个,均P〈0.01];转染siFoxM1的SPC—A-1细胞划痕愈合率(52.6%±7.8%)明显低于转染无关对照siRNA细胞(85.3%±18.6%,P〈0.01)。结论FoxM1基因表达下调可显著降低多种NSCLC细胞的增殖与侵袭能力,提示FoxM1是潜在的肺癌治疗靶点。 Objective To investigate the change of proliferation and invasiveness of non-small cell lung cancer (NSCLC) cell lines SPC-A-1, A549 and LTEP-a-2 with fockhead box M1 (FoxM1) expression deficiency. Methods A siRNA targeting FoxM1 was designed to deplete the FoxM1 expression of these cell lines and an unrelated siRNA used as control. Real-time RT-PCR and Western blotting were used to examine the FoxM1 expression in mRNA and protein level respectively. Colony assay, wound healing assay and transwell chamber assay were employed to evaluate the colony formation ability and invasiveness of FoxM1 deficient cells. Results The designed siRNA could efficiently deplete FoxM1 expression by 83.9%, 83.6% and 88.6% in SPC-A-1, A549 and LTEP-a-2 cell lines respectively. Real-time RT-PCR and Western blot test showed that the FoxMl protein was also depleted. The colony formation numbers ( 136. 0 ± 15.5, 87.0 ±2. 6 and 121.7 ± 9.4 respectively) and invasion cell numbers ( 19. 2 ± 2. 5, 4. 2 ± 0. 8 and 6. 2 ± 1.8 respectively) of FoxMl deficient SPC-A-1, A549 and LTEP-a-2 cell lines were significantly fewer than those of the unrelated-siRNA transfected group (colony formation numbers were 222. 3 ± 20. 5, 164. 7±14. 1 and 260. 7 ± 13.5 respectively, and invasive cell numbers were 81.4 ± 6. 2, 39.2 ±- 4.6 and 35. 6 ± 3.0 respectively, all P 〈 0. 01 ). The cell migration rate of siFoxM1 deficient SPC-A-1 (52.6% ± 7.8% ) was significantly lower than that of the unrelated-siRNA transfeeted group (85.3% _± 18.6% ,P 〈 0. 01). Conclusions The proliferation and invasiveness of several NSCLC cell lines were significantly inhibited after the FoxM1 gene expression was depleted. It suggests that inhibiting the FoxM1 expression might be a promising way for lung cancer therapy.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第34期2424-2428,共5页 National Medical Journal of China
基金 上海市重点学科建设项目(B115)
关键词 非小细胞肺 叉头转录因子类 细胞增殖 肿瘤侵润 RNA干扰 Carcinoma, non-small-cell lung Fockhead transcription factors Cell proliferation Neoplasm invasiveness RNA interference
  • 相关文献

参考文献14

  • 1Kalinichenko VV, Major ML, Wang X, et al. Foxmlb transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the pl9ARF tumor suppressor. Genes Dev, 2004, 18: 830-850.
  • 2Madureira PA, Varshochi R, Constantinidou D, et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem, 2006, 281: 25167-25176.
  • 3Liu M, Dai B, Kang SH, et al. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res, 2006, 66 : 3593-3602.
  • 4Wang Z, Banerjee S, Kong D, et al. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res, 2007, 67: 8293-8300.
  • 5Kim IM, Ackerson T, Ramakrishna S, et al. The Forkhead Box M1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res, 2006, 66 : 2153-2161.
  • 6李昂,闫文生,梁启万,刘继红,王家祥,赵松,方嬿.应用寡核苷酸芯片鉴别肺鳞癌Ⅰb期特异相关基因[J].中华医学杂志,2005,85(37):2623-2628. 被引量:2
  • 7Radhakrishnan SK, Bhat UG, Hughes DE, et al. Identification of a chemical inhibitor of the oncogenic transcription factor Forkhead Box M1. Cancer Res, 2006, 66: 9731-9735.
  • 8Gusarova GA, Wang IC, Major ML, et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. Clin Invest, 2007, 117: 99-111.
  • 9Wang IC, Chen YJ, Hughes D, et al. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem, 2008, 283 : 20770-20778.
  • 10Dai B, Kang SH, Gong W, et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene, 2007, 26 : 6212-6219.

二级参考文献14

  • 1Li A, Zhang XS, Jiang JH, et al. Transeriptional carcinoma and its oncogenic potential. Cell Cycle, 2004,4:304-309.
  • 2The Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nature review, 2004,5:229-237.
  • 3Seifart C, Seifart U, Plagens A, et al. Surfactant protein B gene variations enhance ssceptibility to squamous cell carcinoma of the lung in German patients. Br J Cancer, 2002,15,87:212-217.
  • 4Skriagina EM, Abramovskaia AK, Gurevich CL, et al. Differential diagnosis significance of measuring surfactant phospholipid levels in lung diseases. Probl Tuberk, 1998, 4: 51-53.
  • 5Mao JR, Taylor G, Dean WB, et al. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet,2002, 30:421-425.
  • 6Lau D, Xue L, Hu R, et al. Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis. Am J Respir Cell Mol Biol, 2000, 22: 92-96.
  • 7Lau D, Guo L, Chan A, et al. SPR1. An early molecular marker for bronchial carcinogenesis. Methods Mol Med, 2003, 75:397-403.
  • 8Hu R, Wu R, Deng J, et al. A small proline-rich protein, spr1:specific marker for squamous lung carcinoma. Lung Cancer, 20:25-30.
  • 9Katoh M, Katoh M. Human FOX gene family expression of RPMS1 in nasopharyngeal. Int J Oncol,2004, 25: 1495-500.
  • 10Kalinichenko VV, Major ML, Wang X, et al. Foxm1 b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev,2004, 18:830-850.

共引文献1

同被引文献68

  • 1白莉,祝蓉,陈智鸿,白春学,高磊,张新.靶向EGFR基因的siRNA表达载体构建及其生物学效应的研究[J].第三军医大学学报,2005,27(23):2307-2310. 被引量:9
  • 2王文祥,陈胜喜,文继舫,肖高明,周石林.MMP_2、MMP_9、TIMP_1、TIMP_2和CD44V6在非小细胞肺癌中的表达及与转移、预后的关系[J].中国医学工程,2007,15(2):122-125. 被引量:9
  • 3陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 4Sosa JA,Udelsman R. Papillary thyroid cancer[J].Surgical Oncology Clinics of North America,2006,(03):585-601.doi:10.1016/j.soc.2006.05.010.
  • 5How J,Tobah R. Explaining the increasing incidence of differentiated thyroid cancer[J].Canadian Medical Association Journal,2007,(1 1):1383-1384.doi:10.1503/cmaj.071464.
  • 6Puxeddu E,Moretti S. Clinical Prognosis in BRAF-Mutated PTC[J].Arq Bras Endocrinol Metab,2007,(05):737.
  • 7Kaliniehenko VV,Major ML,Wang X. FoxM1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor[J].Genes and Development,2004,(07):830-850.
  • 8Madureim PA,Varshochi R,Constantinidou D. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer ceils[J].Journal of Biological Chemistry,2006,(35):25167-25176.
  • 9Liu M,Dai B,Kang SH. FoxM1B is overexpressed in human glioblastomns and critic ally regulates the tumorigenicity of glioma cells[J].Cancer Research,2006,(07):3593-3602.
  • 10Wonsey DR,Follettie MT. Loss of the forkhead transcription factor FOXMl causes centrosome amplification and mitotic catastrophe[J].Cancer Research,2005,(12):5181-5189.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部